Publications

1. Schreiber RH, Pendas S, Ku NN, Reintgen DS, Shons AR, Berman C, Boulware D, Cox CE. Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Nodes. Annals of Surgical Oncology Jan/Feb 1999.
2. Cox CE, Bass SS, Boulware D, NiNi KK, Berman C, Reintgen DS. Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma. Annals of Surgical Oncology. September 1999.
3. Krischer J, Lewis H, Boulware D, 1999 Cancer Registry Annual Report. 1999.
4. Karl CK, Schreiber R, Boulware DC, Baker S, Coppola D, Factors Affecting Morbidity, Mortality and Survival in Patients Undergoing Ivor-Lewis Esophagogastrectomy. Annals of Surgery. 2000.
5. Hazlehurst LA, Wisner L, Storey JA, Sullivan DM, Boulware D and Dalton WS. Reduction in drug-induced DNA double strand-breaks associated with ?1 integrin-mediated adhesion correlates with decreased nuclear topoisomerase IIB ?levels in U937 cells. Blood. September 2001.
6. Krischer J, Lewis H, Boulware D, 2000 Cancer Registry Annual Report. 2000.
7. Krischer J, Lewis H, Boulware D, 2001 Cancer Registry Annual Report. 2001.
8. Balducci L, Extermann M, Meyer J, McGinnis M, Tomaszewski T, Corcoran MB, Lazaridis E, Boulware D, Cavanaugh D, Daniel P, Klein C, Effingham K, Mixson H, Yoder J, Haley WE. Comprehensive Geriatric Intervention in Older Breast Cancer Patients: a Pilot. Abstract. American Society of Clinical Oncology. 2001.
9. Szabo M, Irby R, Chambers A, Boulware D, Coppola D, Yeatman T. Osteopontin: a secreted tumor marker correlating with human colon cancer progression. Society of Surgical Oncologists, 55th Annual Meeting, Denver, CO. March 14-17, 2002.
10. Yang I, Bloom G, Boulware D, Kwong K, Coppola D, Quackenbush J, and Yeatman T. A Universal Tumor Classifier Based on Gene Expression. NCI Director's Challenge PI Meeting, Fall 2002.
11. Fallon, P, Gentry T, Balber AE, Boulware D, Janssen J, Smilee R, Storms RW, and Smith CA, Mobilized peripheral blood SSCloALDJbr cells have the phenotypic and functional properties of primitive hematopoietic cells and their number correlates with engraftment following autologous transplantation, British Journal of Haematology, 2003. In Press.
12. Nasir A, Boulware D, Kaiser HE, Coppola D, Yeatman T and Barthel J, COX-2 Expression in Right-Sided versus Left-Sided Colon Cancer: A Rationale For Optimization of Cox-2 Inhibitor Therapy. United States and Canadian Academy of Pathology Annual Meeting. March 22-28, 2003.
13. Nasir A, Boulware D, Kaiser HE, Marcet G, Siegel SE, Bodey B, Yeatman T, Barthel J and Coppola D. Flat Adenocarcinomas of the Colorectum: A Morphologic Analysis of 22 Cases. Digestive Disease Week. Orlando, Florida. May 17-22, 2003.
14. Nasir A, Coppola D, Garret C, Kaiser HE, Bodey B, Boulware D, Yeatman T and Barthel J. Strong Correlation between COX-2 Expression and APC Mutation in Left Vs. Right-Sided Human Colon Cancer - An Immunohistochemical Analysis of 72 Cases. American Society of Clinical Oncology. May 31-June3, 2003.
15. Bolick SCE, Landowski TH, Boulware D, Oshiro MM, Ohkanda J, Hamilton AD, Sebti SM and Dalton WS. The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells. Leukemia. February 2003.
16. Extermann M, Meyer J, McGinnis M, Crocker T, Corcoran M, Yoder J, Haley W, Hongbin C, Boulware D, Balducci L. A Comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Critical Reviews in Oncology-Hematology. In Press.